JM2 Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
JM2 Capital's NVS Position: Q3 2026 in Review
JM2 Capital increased its Novartis (NVS) stake by 7.3% in Q3 2026, buying an estimated $26.4K and bringing the position to 2,548 shares worth $363K. The position accounts for 0.24% of the portfolio, ranked #84.
JM2 Capital first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $394K in Q1 2026. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- JM2 Capital held 2,548 shares of Novartis worth $363K as of Q3 2026.
- JM2 Capital bought 174 Novartis shares in Q3 2026, an estimated $26.4K.
- Novartis made up 0.24% of JM2 Capital's portfolio in Q3 2026, its #84 holding.
- JM2 Capital first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
- JM2 Capital's Novartis position peaked at $394K in Q1 2026.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on JM2 Capital's 13F filing for Q3 2026, filed 14 Oct 2026.